FDA Approves First Gene Therapy for Glycogen Storage Disease Type Ia, Offering Hope and Unanswered Questions
"A groundbreaking gene therapy for a rare metabolic disorder marks a significant advancement, shifting focus from symptom management to addressing the root cause, yet its ultimate impact on patient lives…